✦ LIBER ✦

Langerhans Cell Chimerism After Myeloablative Versus Nonmyeloablative Hematopoietic Cell Transplantation

✍ Scribed by Y. Kirkorian; M. Collin; M. Leboeuf; M. Bogunovic; B. Wood; R.C. Hackman; B. Storer; R. Storb; M. Merad; M. Mielcarek

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of ARF after myeloablative an

✍ Chirag R. Parikh; Robert W. Schrier; Barry Storer; Razvan Diaconescu; Mohamed L. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Chimerism and outcomes after allogeneic

✍ Baron, F; Sandmaier, B M 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 212 KB

T cell (CD3+) chimerism after non-myeloa

✍ R. Sobecks; K. Theil; L. Rybicki; E. Kuczkowski; I. Warshawsky; R. Tubbs; M. Kal 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Graft-versus-host disease after nonmyelo

✍ I.I. Na; H. Shn; E.K. Song; K.W. Lee; S.S. Yoon; J.S. Lee; S. Park; B.K. Kim 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Skin cancer after nonmyeloablative hemat

✍ Cavalier, M; Shmalo, J A; Yu, M; Billings, S D; Abonour, R; Nelson, R P 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Analysis of donor-type chimerism in line

✍ Miura, Y; Tanaka, J; Toubai, T; Tsutsumi, Y; Kato, N; Hirate, D; Kaji, M; Sugita 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 168 KB